by Jonathan Benson, staff writer
(NaturalNews) Just when it seemed like the Johnson & Johnson (J&J) recall saga had come to a close, the company announced yet another recall that includes nearly 50 million units of Tylenol, Benadryl, Rolaids, Sudafed and Sinutab. According to the official press release from McNeil Consumer Healthcare, the pharmaceutical division of J&J that makes these drugs, the currently-recalled product lots were all produced at the Fort Washington, Penn., plant prior to the April 2010 recall, so the company has decided that it is best to pull them for precautionary purposes.
Like many of its previous recalls, the current recall is taking place at the wholesale level, so consumers need not worry about the products available at the retail levels, indicates the press release. The recalled products include Tylenol 8 Hour, Tylenol Arthritis Pain, Tylenol Upper Respiratory, Benadryl, Sudafed PE and Sinutab.
Along with the recall came an announcement that a company investigation revealed poor cleaning procedures as the cause of the company's ongoing quality control issues. J&J says that production equipment was improperly managed, and that cleaning protocols were inadequately performed and documented by employees. Company spokesmen also indicated that J&J has implemented plans to investigate its other plants to ensure that proper protocols are being followed, and that products are being safely produced.
"McNeil has been implementing a Comprehensive Action Plan at its U.S. manufacturing facilities to improve the quality systems at those sites," the company states in a press release. "This product assessment is a key milestone in the implementation of that plan, and the actions being undertaken as a result of the assessment are part of McNeil's ongoing commitment to ensure that all its products meet the high quality standards that consumers expect."
For a full list of McNeil's recalled products throughout the past year, visit:
Sources for this story include: